Another small company's arbitration against CRO th
Post# of 148110
https://endpts.com/arbitration-panel-sides-wi...nrollment/
Quote:
The contract research organization Syneos Health didn’t hold up its end of the deal and use “commercially reasonable efforts” when setting up a trial for a biotech client, an arbitration panel found. It also determined that the client owes the CRO about $1.7 million in damages — less than half of what Syneos was asking for in payment.
FSD Pharma, which contracted Syneos to set up a Phase II trial in 2021 for one of its drug candidates dubbed FSD 210, claimed in a statement Monday that Syneos failed to enroll the expected number of patients and hit enrollment deadlines.
The small company had to pay 1.7 million to the rotten CRO because they didn't dispute the bills "properly," whatever that means.